User profiles for M. Frost

Morten Frost

- Verified email at health.sdu.dk - Cited by 4917

Michael Bom Frøst

- Verified email at food.ku.dk - Cited by 4229

Megan Frost

- Verified email at sterilestate.com - Cited by 3419

Bone fragility in diabetes: novel concepts and clinical implications

…, B Busse, R Eastell, S Ferrari, M Frost… - The Lancet Diabetes & …, 2022 - thelancet.com
Increased fracture risk represents an emerging and severe complication of diabetes. The
resulting prolonged immobility and hospitalisations can lead to substantial morbidity and …

Polymers incorporating nitric oxide releasing/generating substances for improved biocompatibility of blood-contacting medical devices

MC Frost, MM Reynolds, ME Meyerhoff - Biomaterials, 2005 - Elsevier
The current state-of-the-art with respect to the preparation, characterization and biomedical
applications of novel nitric oxide (NO) releasing or generating polymeric materials is …

[HTML][HTML] Changing children's eating behaviour-A review of experimental research

P DeCosta, P Møller, MB Frøst, A Olsen - Appetite, 2017 - Elsevier
The interest in children's eating behaviours and how to change them has been growing in
recent years. This review examines the following questions: What strategies have been used …

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

…, C Cooper, G Dedoussis, I Ford, M Frost… - Nature …, 2012 - nature.com
Bone mineral density (BMD) is the most widely used predictor of fracture risk. We performed
the largest meta-analysis to date on lumbar spine and femoral neck BMD, including 17 …

[HTML][HTML] Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer

…, JL Johnson, SK McDonnell, MH Frost… - … England Journal of …, 1999 - Mass Medical Soc
Background Options for women at high risk for breast cancer include surveillance,
chemoprevention, and prophylactic mastectomy. The data on the outcomes for surveillance and …

[HTML][HTML] Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

…, A DebRoy, PL Chen, S Sparagana, MD Frost - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is highly variable in clinical presentation and
findings. Disease manifestations continue to develop over the lifetime of an affected individual. …

[HTML][HTML] Benign breast disease and the risk of breast cancer

LC Hartmann, TA Sellers, MH Frost… - … England Journal of …, 2005 - Mass Medical Soc
Background Benign breast disease is an important risk factor for breast cancer. We studied
a large group of women with benign breast disease to obtain reliable estimates of this risk. …

[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations

…, DW Dunn, R Ekong, KC Ess, DN Franz, M Frost… - Pediatric Neurology, 2021 - Elsevier
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo …

…, E Belousova, S Sparagana, EM Bebin, M Frost… - The Lancet, 2013 - thelancet.com
… UK, Italy, the Netherlands, Poland, Russian Federation, and the USA were randomly assigned,
with an interactive internet-response system, in a 2:1 ratio to oral everolimus 4·5 mg/m 2 …

[HTML][HTML] Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

…, A DebRoy, PL Chen, S Sparagana, MD Frost - Pediatric …, 2013 - Elsevier
Background Tuberous sclerosis complex is a genetic disorder affecting every organ system,
but disease manifestations vary significantly among affected individuals. The diverse and …